Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Kirn

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Methods in Molecular Medicine|March 11, 2011
A Phase II Trial of Intratumoral Injection with a Selectively Replicating Adenovirus (ONYX-015) in Patients with Recurrent, Refractory Squamous Cell Carcinoma of the Head and NeckD H Kirn
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2011
Redemption for the field of oncolytic virotherapyDavid H Kirn
The Journal of Clinical Investigation|April 5, 2000
Replication-selective microbiological agents: fighting cancer with targeted germ warfareD H Kirn
Gene Therapy|June 14, 2000
A tale of two trials: selectively replicating herpesviruses for brain tumorsD H Kirn
The Journal of Clinical Investigation|April 5, 2000
Replication-selective adenoviruses as oncolytic agentsC Heise, D H Kirn
Journal of the National Cancer Institute|June 5, 1996
Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytomaD H Kirn, A Kramer
Molecular Medicine Today|December 1, 1996
Replicating viruses as selective cancer therapeuticsD H Kirn, F McCormick
Expert Opinion on Biological Therapy|July 23, 2004
Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virusSteve H Thorne, David H Kirn
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and developmentTerry W Hermiston, D H Kirn
Nature Reviews. Cancer|December 24, 2008
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancerDavid H Kirn, Steve H Thorne
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Methods in Molecular Medicine|March 11, 2011
A Phase II Trial of Intratumoral Injection with a Selectively Replicating Adenovirus (ONYX-015) in Patients with Recurrent, Refractory Squamous Cell Carcinoma of the Head and NeckD H Kirn
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2011
Redemption for the field of oncolytic virotherapyDavid H Kirn
The Journal of Clinical Investigation|April 5, 2000
Replication-selective microbiological agents: fighting cancer with targeted germ warfareD H Kirn
Gene Therapy|June 14, 2000
A tale of two trials: selectively replicating herpesviruses for brain tumorsD H Kirn
The Journal of Clinical Investigation|April 5, 2000
Replication-selective adenoviruses as oncolytic agentsC Heise, D H Kirn
Journal of the National Cancer Institute|June 5, 1996
Long-term freedom from disease progression with interferon alfa therapy in two patients with malignant hemangiopericytomaD H Kirn, A Kramer
Molecular Medicine Today|December 1, 1996
Replicating viruses as selective cancer therapeuticsD H Kirn, F McCormick
Expert Opinion on Biological Therapy|July 23, 2004
Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virusSteve H Thorne, David H Kirn
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 18, 2005
Genetically based therapeutics for cancer: similarities and contrasts with traditional drug discovery and developmentTerry W Hermiston, D H Kirn
Nature Reviews. Cancer|December 24, 2008
Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancerDavid H Kirn, Steve H Thorne
Pageof 8